Curcumin ameliorates hepatic chronic inflammation induced by bile duct obstruction in mice through the activation of heme oxygenase-1
Graphical abstract
Introduction
Many hepatic diseases, such as gallstones, obstructive jaundice, acute hepatitis, biliary atresia, cystic fibrosis, primary sclerosing cholangitis and primary biliary cirrhosis, often lead to hepatic cholestasis [1]. The blockage of bile flow from the hepatocytes to the intestine leads to bile acid accumulation in the liver tissue, resulting in inflammation, oxidative stress, apoptosis and fibrosis. Nevertheless, ursodeoxycholic acid and obeticholic acid is the only clinically approved treatment for chronic cholestatic liver disease until now [2]. Nowadays, there are no anti-inflammatory agent available to inhibit inflammation induced by chronic hepatic cholestasis. Therefore, it is extremely important to develop new anti-inflammatory components for cholestasis.
It has been recognized that bioactive foods and natural products have antifibrotic effects. Identification of natural products and bioactive food components is vital to develop effective preventive/therapeutic strategies against hepatic fibrosis [3]. Curcumin (Cur), a natural yellow polyphenol, is isolated from rhizome of turmeric (Curcuma longa). Cur has anti-oxidant, anti-inflammatory, anti-mutagenic and anti-carcinogenic properties and is expected to treat and to have prophylactic effects on different diseases [4], [5]. Additionally, more and more studies have unequivocally recognized that Cur has powerful hepatoprotective effects. Cur significantly attenuated TNF-α-induced liver steatosis [6] and CCl4- induced acute liver injury in rats [7]; Cur also could recover the lipid metabolism homeostasis in oleic acid-stimulated hepatocarcinoma cells [8]. However, the molecular mechanisms underlying the protective role of Cur on hepatic diseases has not been fully explored.
Heme oxygenase-1 (HO-1) exerts antioxidant anti-inflammatory and cytoprotective effects through its by-products by degrading heme [9], [10]. Several studies have reported that Cur could up-regulated HO-1 and dampened various liver diseases such as acute liver injury, alcoholic liver disease and liver fibrosis [11], [12], [13], but it is not clear that the role of HO-1 on the protective effect of Cur against hepatic cholestasis. In this study, we found that HO-1 contributed to the protective effect of Cur against hepatic cholestasis in BDL mice.
Section snippets
Reagents and antibodies
Curcumin (Cat # C1386, purity ≥ 95% by HPLC), zinc protoporphyrin IX (ZnPP, Cat # 282820, purity ≥ 95% by HPLC), P450 reductase (Cat #C8113), β-NADPH (Cat #N5130) were purchased from Sigma-Aldrich Chemical (St. Louis, MO, USA). Aspartate aminotransferase (AST), alanine aminotransferase (ALT) were purchased from Nanjing Jiancheng (China). Primary antibodies for anti-HO-1 (Cat # ab13248), MPO (Cat # ab9535) were obtained from Abcam (Abcam, USA). F4/80 (Cat #MCA497GA) and 4′,6-
The abnormal liver function and serious liver fibrosis in BDL mice
We performed operation of bile duct ligation in 20 male mice and euthanized them at 7 d and 14 d after surgery to investigate different phase of liver fibrogenesis. Compared with the control group and sham group mice, the gall bladders of BDL mice were filled with large quantities of bile at the 7th day and even aggravated after 14 days (Fig. 1A). At the 7th day, the content of ALT and AST was higher than 14th day while the total bilirubin and direct bilirubin constantly increased during the
Discussion
Although Cur has received more attention over the years as a promising preventive and treatment agent for many hepatic diseases, its defined mechanisms on hepatoprotective effects are largely unknown. In this study, we demonstrated for the first time that Cur could up-regulated the expression and activities of HO-1, and facilitated its nuclear translocation. Noteworthily, Cur could effectively reverse this abnormal lipid metabolism in BDL mice. HO-1 activity inhibitor (ZnPP), abolished these
Declaration of Competing Interest
The authors declared that there is no conflict of interest.
Acknowledgments
This study was supported by the grants from the project supported by the following grants: National Natural Science Foundation of China, China (81871518, 81901522, 81702799); National first-class discipline program of Food Science and Technology, China (JUFSTR20180101); Wuxi health and family planning commission, China (Z201810); Public Health Research center at Jiangnan University, China (JUPH201805); Fundamental Research Funds for the Central Universities, China (JUSRP11955).
References (41)
- et al.
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond
J. Hepatol.
(2015) - et al.
Food components with antifibrotic activity and implications in prevention of liver disease
J. Nutrit. Biochem.
(2018) - et al.
The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites
J. Biol. Chem.
(2017) - et al.
Aminoguanidine and curcumin attenuated tumor necrosis factor (TNF)-alpha-induced oxidative stress, colitis and hepatotoxicity in mice
Int. Immunopharmacol.
(2012) - et al.
Heme oxygnease-1 induction by methylene blue protects RAW264.7 cells from hydrogen peroxide-induced injury
Biochem. Pharmacol.
(2018) - et al.
Heme-dependent metabolite switching regulates H2S synthesis in response to endoplasmic reticulum (ER) stress
J. Biol. Chem.
(2016) - et al.
Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients
J. Hepatol.
(2005) - et al.
A Curcumin aggravates CNS pathology in experimental systemic lupus erythematosus
Brain Res.
(2013) - et al.
Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics
J. Lipid Res.
(2008) - et al.
Curcumin attenuates quinocetone induced apoptosis and inflammation via the opposite modulation of Nrf2/HO-1 and NF-kB pathway in human hepatocyte L02 cells
Food Chem. Toxicol. Int. J. Publ. Brit. Ind. Biol. Res. Assoc.
(2016)
Nuclear heme oxygenase-1 (HO-1) modulates subcellular distribution and activation of Nrf2, impacting metabolic and anti-oxidant defenses
J. Biol. Chem.
Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas
Exp. Mol. Pathol.
Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats
J. Hepatol.
Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: potential role for silent information regulator 1 (SIRT1)
Toxicol. Appl. Pharmacol.
High-fat enteral nutrition reduces endotoxin, tumor necrosis factor-alpha and gut permeability in bile duct-ligated rats subjected to hemorrhagic shock
J. Hepatol.
Effects of curcumin on HDL functionality
Pharmacol. Res.
The role of phosphatidylcholine and deoxycholic acid in inflammation
Life Sci.
Hepatoprotective effect of phosphatidylcholine against carbon tetrachloride liver damage in mice
Biochem. Biophys. Res. Commun.
New aspects of lipotoxicity in nonalcoholic steatohepatitis
Int. J. Mol. Sci.
Discovery of curcumin, a component of golden spice, and its miraculous biological activities
Clin. Exp. Pharmacol. Physiol.
Cited by (6)
A sojourn into therapeutic and nutraceutical potential of curcumin and its novel drug delivery system: Current achievements and future perspectives
2022, South African Journal of BotanyCitation Excerpt :In another study it was seen that curcumin could decrease acute pancreatitis via anti-oxidant, anti-apoptosis and anti-inflammation property resulting in decreased pancreatic damage (Siriviriyakul et al., 2019). In a recent study the authors have reported that curcumin exerted protective effects against hepatic chronic inflammation induced by bile duct obstruction in mice possibly via upregulating HO-1, thus can be helpful in mitigating chronic cholestatic liver diseases (Chen et al., 2020a). The results of another study revealed that pretreatment with curcumin for 30 days and/or rutin prevented the inflammation induced by hyperlipidemia in Wistar rats (Manzoni et al., 2019).
Dietary Polyphenols Alleviate Autoimmune Liver Disease by Mediating the Intestinal Microenvironment: Challenges and Hopes
2022, Journal of Agricultural and Food ChemistryNatural Compounds as Heme Oxygenase-1 Inducers to Reduce the Deleterious Consequences Following SARS-CoV-2 Infection
2021, Current Chemical Biology
- 1
These authors contributed equally to this work.